eczema. Atopic dermatitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The eczema diagnosis has been confirmed by a dermatologist in all individuals All ages and both genders with mild to moderate eczema severity, as assessed by the Eczema Area and Severity Index (EASI) Patients must not have used topical or systemic treatments for at least three months prior to the start of the study Willingness to cooperate in the study and complete the informed consent form
Exclusion criteria
Exclusion criteria: Patients with weeping lesions Patients with lesions that have been burned or traumatized Hypersensitivity to the ingredients of the medication Patients who have another active skin disease in addition to eczema Kidney and liver dysfunction Involvement with uncontrolled chronic diseases Pregnancy and breastfeeding Individuals who have participated in other clinical trials in the past 1 month
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of eczema. Timepoint: Before the intervention and 2 weeks after the end of the intervention. Method of measurement: Eczema Area and Severity Index (EASI). | — |
Countries
Iran (Islamic Republic of)
Contacts
Shiraz University of Medical Sciences